Patent | Date |
---|
Compound For Treating Gout Or Hyperuricemia App 20220242841 - YAN; Shunqi ;   et al. | 2022-08-04 |
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia App 20220112171 - YAN; Shunqi ;   et al. | 2022-04-14 |
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia Grant 11,236,058 - Yan , et al. February 1, 2 | 2022-02-01 |
Methods For Treating Or Preventing Gout Or Hyperuricemia App 20220023251 - YAN; Shunqi ;   et al. | 2022-01-27 |
Crystalline Forms Of A Compound For Treating Or Preventing Gout Or Hyperuricemia App 20220024889 - YAN; Shunqi ;   et al. | 2022-01-27 |
Therapeutic Compounds And Compositions App 20210198206 - Salituro; Francesco G. ;   et al. | 2021-07-01 |
Therapeutic compounds and compositions Grant 10,988,448 - Salituro , et al. April 27, 2 | 2021-04-27 |
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia App 20200148659 - YAN; Shunqi ;   et al. | 2020-05-14 |
Therapeutically Active Compounds And Their Methods Of Use App 20200079755 - Cianchetta; Giovanni ;   et al. | 2020-03-12 |
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia Grant 10,508,093 - Yan , et al. Dec | 2019-12-17 |
Therapeutic Compounds And Compositions App 20190345109 - Salituro; Francesco G. ;   et al. | 2019-11-14 |
Glutaminase inhibitors and method of use Grant 10,414,740 - Lemieux , et al. Sept | 2019-09-17 |
Therapeutic Compounds And Compositions App 20190241523 - Salituro; Francesco G. ;   et al. | 2019-08-08 |
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia App 20190169150 - YAN; Shunqi ;   et al. | 2019-06-06 |
Therapeutically active compounds and their methods of use Grant 10,294,215 - Cianchetta , et al. | 2019-05-21 |
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia Grant 10,239,854 - Yan , et al. | 2019-03-26 |
Therapeutic compounds and compositions Grant 10,202,339 - Popovici-Muller , et al. Feb | 2019-02-12 |
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia App 20190040030 - YAN; Shunqi ;   et al. | 2019-02-07 |
Glutaminase Inhibitors And Method Of Use App 20180370930 - Lemieux; Rene M. ;   et al. | 2018-12-27 |
Therapeutic compounds and compositions Grant 10,029,987 - Salituro , et al. July 24, 2 | 2018-07-24 |
Glutaminase inhibitors and method of use Grant 10,011,574 - Lemieux , et al. July 3, 2 | 2018-07-03 |
Therapeutically active compositions and their methods of use Grant 9,856,279 - Cao , et al. January 2, 2 | 2018-01-02 |
Therapeutically Active Compounds And Their Methods Of Use App 20170298045 - Cianchetta; Giovanni ;   et al. | 2017-10-19 |
Therapeutically active compounds and their methods of use Grant 9,732,062 - Cianchetta , et al. August 15, 2 | 2017-08-15 |
Therapeutically Active Compositions And Their Methods Of Use App 20170210749 - Cao; Sheldon ;   et al. | 2017-07-27 |
Inhibitors of bruton's tyrosine kinase Grant 9,708,326 - Chen , et al. July 18, 2 | 2017-07-18 |
Therapeutic Compounds And Compositions App 20170183311 - Salituro; Francesco G. ;   et al. | 2017-06-29 |
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer Grant 9,662,327 - Cao , et al. May 30, 2 | 2017-05-30 |
Therapeutically active compounds and their methods of use Grant 9,656,999 - Cianchetta , et al. May 23, 2 | 2017-05-23 |
Inhibitors of Bruton's tyrosine kinase Grant 9,580,416 - Chen , et al. February 28, 2 | 2017-02-28 |
Therapeutically Active Compounds And Their Methods Of Use App 20170044139 - Cianchetta; Giovanni ;   et al. | 2017-02-16 |
Purinone Compounds As Kinase Inhibitors App 20160368924 - Chen; Wei ;   et al. | 2016-12-22 |
Therapeutically active compositions and their methods of use Grant 9,512,107 - Cianchetta , et al. December 6, 2 | 2016-12-06 |
Therapeutically Active Compositions And Their Methods Of Use App 20160318903 - Cianchetta; Giovanni ;   et al. | 2016-11-03 |
Therapeutically Active Compounds And Their Methods Of Use App 20160304556 - Popovici-Muller; Janeta ;   et al. | 2016-10-20 |
Purinone compounds as kinase inhibitors Grant 9,469,642 - Chen , et al. October 18, 2 | 2016-10-18 |
Therapeutically Active Compositions And Their Methods Of Use App 20160264621 - Popovici-Muller; Janeta ;   et al. | 2016-09-15 |
Therapeutically Active Compositions And Their Methods Of Use App 20160229876 - Cao; Sheldon ;   et al. | 2016-08-11 |
Compounds and their methods of use Grant 9,303,002 - Lemieux , et al. April 5, 2 | 2016-04-05 |
Inhibitors Of Bruton's Tyrosine Kinase App 20160002241 - CHEN; Wei ;   et al. | 2016-01-07 |
Inhibitors Of Bruton's Tyrosine Kinase App 20160002225 - CHEN; Wei ;   et al. | 2016-01-07 |
N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators Grant 9,221,792 - Salituro , et al. December 29, 2 | 2015-12-29 |
Therapeutic compounds and compositions Grant 9,199,968 - Salituro , et al. December 1, 2 | 2015-12-01 |
Glutamase Inhibitors And Method Of Use App 20150299152 - Lemieux; Rene M. ;   et al. | 2015-10-22 |
Therapeutic Compounds And Compositions App 20150299115 - Popovici-Muller; Janeta ;   et al. | 2015-10-22 |
Therapeutic Compounds And Compositions App 20150183760 - Salituro; Francesco G. ;   et al. | 2015-07-02 |
Therapeutically Active Compounds And Their Methods Of Use App 20150087600 - Popovici-Muller; Janeta ;   et al. | 2015-03-26 |
Therapeutic compounds and compositions Grant 8,889,667 - Salituro , et al. November 18, 2 | 2014-11-18 |
Therapeutic Compounds And Compositions App 20140323467 - Salituro; Francesco G. ;   et al. | 2014-10-30 |
Therapeutically Active Compositions And Their Methods Of Use App 20140213580 - Cao; Sheldon ;   et al. | 2014-07-31 |
Therapeutically Active Compositions And Their Methods Of Use App 20140206673 - Cao; Sheldon ;   et al. | 2014-07-24 |
Therapeutic compounds and compositions Grant 8,785,450 - Salituro , et al. July 22, 2 | 2014-07-22 |
Compounds And Their Methods Of Use App 20140142146 - Lemieux; Rene M. ;   et al. | 2014-05-22 |
Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors Grant 8,716,318 - Yan , et al. May 6, 2 | 2014-05-06 |
Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors Grant 8,673,919 - Vernier , et al. March 18, 2 | 2014-03-18 |
Novel N-(4-(azetidine-1-carbonyl) Phenyl) - (hetero-) Arylsulfonamide Derivatives As Pyruvate Kinase M2 (pmk2) Modulators App 20140073625 - Salituro; Francesco G. ;   et al. | 2014-03-13 |
Therapeutically Active Compounds And Their Methods Of Use App 20130190287 - Cianchetta; Giovanni ;   et al. | 2013-07-25 |
Therapeutically Active Compositions And Their Methods Of Use App 20130184222 - Popovici-Muller; Janeta ;   et al. | 2013-07-18 |
Therapeutic Compounds And Compositions App 20120172349 - Salituro; Francesco G. ;   et al. | 2012-07-05 |
Dihydropyridin Sulfonamides And Dihydropyridin Sulfamides As Mek Inhibitors App 20120107307 - Vernier; Jean-Michel ;   et al. | 2012-05-03 |
Pyridone Sulfonamides And Pyridone Sulfamides As Mek Inhibitors App 20110112152 - Yan; Shunqi ;   et al. | 2011-05-12 |
Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors Grant 7,897,624 - Yan , et al. March 1, 2 | 2011-03-01 |
Therapeutic Compounds And Compositions App 20100331307 - Salituro; Francesco G. ;   et al. | 2010-12-30 |
N-aryl-N'alkyl sulfamides as MEK inhibitors Grant 7,842,836 - Yan , et al. November 30, 2 | 2010-11-30 |
Pyridone Sulfonamides And Pyridone Sulfamides As Mek Inhibitors App 20070244164 - Yan; Shunqi ;   et al. | 2007-10-18 |
N-aryl-n'alkyl Sulfamides As Mek Inhibitors App 20070238710 - Yan; Shunqi ;   et al. | 2007-10-11 |
Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus App 20060217390 - Gunic; Esmir ;   et al. | 2006-09-28 |